Medication

President Donald Trump tells reporters that he is taking zinc and hydroxychloroquine during a meeting with restaurant industry executives about the coronavirus response, in the State Dining Room of the White House, Monday, May 18, 2020, in Washington. (AP Photo/Evan Vucci)
AP News
May 18, 2020 - 4:29 pm
WASHINGTON (AP) — President Donald Trump said Monday that he is taking a malaria drug to protect against the new coronavirus, despite warnings from his own government that it should only be administered for COVID-19 in a hospital or research setting due to potentially fatal side effects. Trump told...
Read More
Veterans Affairs Secretary Robert Wilkie speaks about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
May 15, 2020 - 9:14 pm
WASHINGTON (AP) — Facing growing criticism, the Department of Veterans Affairs said Friday that it will not halt use of an unproven malaria drug on veterans with COVID-19 but that fewer of its patients are now taking it. In responses provided to Congress and obtained by The Associated Press, the VA...
Read More
Richard Bright, former director of the Biomedical Advanced Research and Development Authority, arrives for a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus outbreak, Thursday, May 14, 2020 on Capitol Hill in Washington. (Greg Nash/Pool via AP)
May 14, 2020 - 1:42 pm
WASHINGTON (AP) — Despite White House claims, the U.S. still lacks a comprehensive battle plan against the coronavirus in critical areas including masks, testing, treatments and vaccines, whistleblower Rick Bright warned Thursday in testimony before a House committee. “Our window of opportunity is...
Read More
FILE - In this March 16, 2020 file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. In a press briefing on Thursday May 14, 2020, the European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” (AP Photo/Ted S. Warren, File)
May 14, 2020 - 4:19 am
LONDON (AP) — The European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” Dr. Marco Cavaleri, who heads the European regulator’s vaccines department...
Read More
Veterans Affairs Secretary Robert Wilkie talks before President Donald Trump arrives to speak about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
May 10, 2020 - 6:15 am
WASHINGTON (AP) — The Senate’s top Democrat on Sunday called on the Department of Veterans Affairs to explain why it allowed the use of an unproven drug on veterans for the coronavirus, saying patients may have been put at unnecessary risk. Sen. Charles Schumer of New York said the VA needs to...
Read More
White House coronavirus response coordinator Dr. Deborah Birx listens as President Donald Trump holds a meeting about the coronavirus response with Gov. Greg Abbott, R-Texas, in the Oval Office of the White House, Thursday, May 7, 2020, in Washington. (AP Photo/Evan Vucci)
May 08, 2020 - 3:00 pm
WASHINGTON (AP) — Trying to head off another chaotic scramble for scarce supplies, the White House said Friday it will step in to help coordinate distribution of the first drug that appears to help some COVID-19 patients recover faster. Press Secretary Kayleigh McEnany told reporters that Dr...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine tablets in Las Vegas. According to results released on Thursday, May 7, 2020, a new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 consecutive patients treated at Columbia University Irving Medical Center in New York. (AP Photo/John Locher)
May 07, 2020 - 2:17 pm
A new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 patients treated at Columbia University in New York,...
Read More
FILE - In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Gilead Sciences via AP)
May 01, 2020 - 3:08 pm
WASHINGTON (AP) — U.S. regulators on Friday allowed emergency use of the first drug that appears to help some COVID-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus. The Food and Drug Administration said in a statement that Gilead Science’...
Read More
Workers manufacture face masks at a workshop in Bogota, Colombia, Wednesday, April 29, 2020. Oscar Henao a taxi driver by profession and his partner Adan Fajardo, owner of the small packaging workshop, created the plastic protection mask model they called the "mask of life,” to protect people from the coronavirus pandemic. (AP Photo/Fernando Vergara)
April 29, 2020 - 7:53 pm
Scientists on Wednesday announced the first effective treatment against the coronavirus — an experimental drug that can speed the recovery of COVID-19 patients — in a major medical advance that came as the economic gloom caused by the scourge deepened in the U.S. and Europe. The U.S. government...
Read More
FILE - In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. On Wednesday, April 29, 2020, the company says its experimental antiviral drug has proved effective against the new coronavirus in a major U.S. government study that put it to a strict test. (Gilead Sciences via AP)
April 29, 2020 - 10:31 am
An experimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, U.S. government and company officials announced Wednesday. Gilead Sciences’s remdesivir is the first treatment to pass such a strict...
Read More

Pages